SCHEMBL27156307

SCHEMBL27156307

O=C(O)c1c(C(=O)O)c2c(Br)cc3ccccc3n2c1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.42
▸ FNTA P49354 3/20 0.41
▸ FNTB P49356 3/20 0.41
▸ CCR2 P41597 1/20 0.40
▸ MAPT P10636 6/20 0.38
▸ NPSR1 Q6W5P4 4/20 0.38
▸ POLB P06746 1/20 0.38
▸ SRD5A2 P31213 1/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CNR2 P34972 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156314 0.92 DAO (0.37) FNTAFNTBCCR2MAPTCYP1A2
SCHEMBL27156306 0.91 AKR1C3 (0.43) FNTAFNTBMAPTPOLBCYP1A2
SCHEMBL27156303 0.88 NPC1 (0.37) FNTAFNTBMAPTNPSR1POLB
SCHEMBL27156311 0.85 RAB9A (0.40) MAPTNPSR1POLBCYP1A2CYP2D6
SCHEMBL27156310 0.85 TRPA1 (0.37) FNTAFNTBPOLBMEN1KMT2A
SCHEMBL30816139 0.84 KMT2A (0.39) FNTAFNTBMAPTNPSR1POLB
SCHEMBL28458417 0.77 MAPT (0.36) MAPTNPSR1CYP1A2CYP2D6CYP2C9
SCHEMBL27181989 0.77 DHODH (0.40) NR4A1FNTAFNTBMAPTNPSR1
SCHEMBL30816138 0.77 HPGD (0.41) MAPTNPSR1CYP1A2CYP2D6CYP2C9
SCHEMBL27156301 0.76 MEN1 (0.39) MAPTPOLBL3MBTL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents King Faisal University (SA) 2024-03-05 — — US claimed
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents King Faisal University (SA) 2024-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919900-B1 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents BRD4, BET1, TALDO1 NR4A1 910/4885FNTA 720/4885FNTB 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback